246 related articles for article (PubMed ID: 31375592)
1. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C; Beiss V; Steinmetz NF
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
[TBL] [Abstract][Full Text] [Related]
2. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
[TBL] [Abstract][Full Text] [Related]
3. Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves
Shukla S; Wang C; Beiss V; Steinmetz NF
ACS Nano; 2020 Mar; 14(3):2994-3003. PubMed ID: 32133838
[TBL] [Abstract][Full Text] [Related]
4. Freeze-Drying To Produce Efficacious CPMV Virus-like Particles.
Zheng Y; Lee PW; Wang C; Thomas LD; Stewart PL; Steinmetz NF; Pokorski JK
Nano Lett; 2019 Mar; 19(3):2099-2105. PubMed ID: 30801195
[TBL] [Abstract][Full Text] [Related]
5. Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.
Mao C; Beiss V; Fields J; Steinmetz NF; Fiering S
Biomaterials; 2021 Aug; 275():120914. PubMed ID: 34126409
[TBL] [Abstract][Full Text] [Related]
6. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
7. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
8. The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA.
Jung E; Chung YH; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jul; 20(7):3589-3597. PubMed ID: 37294891
[TBL] [Abstract][Full Text] [Related]
9. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
[TBL] [Abstract][Full Text] [Related]
10. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade.
Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
[TBL] [Abstract][Full Text] [Related]
12. The unique potency of Cowpea mosaic virus (CPMV)
Shukla S; Wang C; Beiss V; Cai H; Washington T; Murray AA; Gong X; Zhao Z; Masarapu H; Zlotnick A; Fiering S; Steinmetz NF
Biomater Sci; 2020 Sep; 8(19):5489-5503. PubMed ID: 32914796
[TBL] [Abstract][Full Text] [Related]
13. Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.
Jung E; Mao C; Bhatia M; Koellhoffer EC; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jan; 20(1):500-507. PubMed ID: 36399598
[TBL] [Abstract][Full Text] [Related]
14. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
Nkanga CI; Steinmetz NF
ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
[TBL] [Abstract][Full Text] [Related]
15. Genetic engineering and characterization of Cowpea mosaic virus empty virus-like particles.
Sainsbury F; Saxena P; Aljabali AA; Saunders K; Evans DJ; Lomonossoff GP
Methods Mol Biol; 2014; 1108():139-53. PubMed ID: 24243247
[TBL] [Abstract][Full Text] [Related]
16. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.
Lizotte PH; Wen AM; Sheen MR; Fields J; Rojanasopondist P; Steinmetz NF; Fiering S
Nat Nanotechnol; 2016 Mar; 11(3):295-303. PubMed ID: 26689376
[TBL] [Abstract][Full Text] [Related]
17. Cowpea Mosaic Virus Promotes Anti-Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model.
Wang C; Fiering SN; Steinmetz NF
Adv Ther (Weinh); 2019 May; 2(5):. PubMed ID: 33969181
[TBL] [Abstract][Full Text] [Related]
18. CD47 Blockade and Cowpea Mosaic Virus Nanoparticle In Situ Vaccination Triggers Phagocytosis and Tumor Killing.
Wang C; Steinmetz NF
Adv Healthc Mater; 2019 Apr; 8(8):e1801288. PubMed ID: 30838815
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer.
Alonso-Miguel D; Valdivia G; Guerrera D; Perez-Alenza MD; Pantelyushin S; Alonso-Diez A; Beiss V; Fiering S; Steinmetz NF; Suarez-Redondo M; Vom Berg J; Peña L; Arias-Pulido H
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35277459
[TBL] [Abstract][Full Text] [Related]
20. A co-formulated vaccine of irradiated cancer cells and cowpea mosaic virus improves ovarian cancer rejection.
Zhao Z; Ortega-Rivera OA; Chung YH; Simms A; Steinmetz NF
J Mater Chem B; 2023 Jun; 11(24):5429-5441. PubMed ID: 36861401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
